These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 22515108)

  • 1. Adipocytokines and obesity-linked disorders.
    Ouchi N; Ohashi K; Shibata R; Murohara T
    Nagoya J Med Sci; 2012 Feb; 74(1-2):19-30. PubMed ID: 22515108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.
    Jung UJ; Choi MS
    Int J Mol Sci; 2014 Apr; 15(4):6184-223. PubMed ID: 24733068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular diseases and metabolic abnormalities associated with obesity: What is the role of inflammatory responses? A systematic review.
    Hamjane N; Benyahya F; Nourouti NG; Mechita MB; Barakat A
    Microvasc Res; 2020 Sep; 131():104023. PubMed ID: 32485192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective Roles of Adipocytokines and Myokines in Cardiovascular Disease.
    Ouchi N; Ohashi K; Shibata R; Murohara T
    Circ J; 2016 Sep; 80(10):2073-80. PubMed ID: 27581346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipokines: a link between obesity and cardiovascular disease.
    Nakamura K; Fuster JJ; Walsh K
    J Cardiol; 2014 Apr; 63(4):250-9. PubMed ID: 24355497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular effects of novel adipocytokines: focus on vascular contractility and inflammatory responses.
    Yamawaki H
    Biol Pharm Bull; 2011; 34(3):307-10. PubMed ID: 21372376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease.
    Fuster JJ; Ouchi N; Gokce N; Walsh K
    Circ Res; 2016 May; 118(11):1786-807. PubMed ID: 27230642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipocytokines in obesity and metabolic disease.
    Cao H
    J Endocrinol; 2014 Feb; 220(2):T47-59. PubMed ID: 24403378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipokines at the crossroad between obesity and cardiovascular disease.
    Molica F; Morel S; Kwak BR; Rohner-Jeanrenaud F; Steffens S
    Thromb Haemost; 2015 Mar; 113(3):553-66. PubMed ID: 25338625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipocytokines and the metabolic complications of obesity.
    Rasouli N; Kern PA
    J Clin Endocrinol Metab; 2008 Nov; 93(11 Suppl 1):S64-73. PubMed ID: 18987272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease].
    Kravchun P; Kadykova O; Gabisoniia T
    Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cardiovascular health and disease by visceral adipose tissue-derived metabolic hormones.
    Vasamsetti SB; Natarajan N; Sadaf S; Florentin J; Dutta P
    J Physiol; 2023 Jun; 601(11):2099-2120. PubMed ID: 35661362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemerin in human cardiovascular disease.
    Kaur J; Mattu HS; Chatha K; Randeva HS
    Vascul Pharmacol; 2018 Nov; 110():1-6. PubMed ID: 30016719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipocytokines: Are they the Theory of Everything?
    Maximus PS; Al Achkar Z; Hamid PF; Hasnain SS; Peralta CA
    Cytokine; 2020 Sep; 133():155144. PubMed ID: 32559663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases.
    Matsuda M; Shimomura I
    Rev Endocr Metab Disord; 2014 Mar; 15(1):1-10. PubMed ID: 24026768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity and metabolic syndrome: an inflammatory condition.
    Scarpellini E; Tack J
    Dig Dis; 2012; 30(2):148-53. PubMed ID: 22722429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipocytokines in Cardiovascular and Metabolic Diseases.
    Ouchi N
    J Atheroscler Thromb; 2016 Jun; 23(6):645-54. PubMed ID: 27087513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging functions of adipokines in linking the development of obesity and cardiovascular diseases.
    Su X; Peng D
    Mol Biol Rep; 2020 Oct; 47(10):7991-8006. PubMed ID: 32888125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory processes in obesity: focus on endothelial dysfunction and the role of adipokines as inflammatory mediators.
    Singh M; Benencia F
    Int Rev Immunol; 2019; 38(4):157-171. PubMed ID: 31286783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipokines in inflammation, insulin resistance and cardiovascular disease.
    Li ZY; Wang P; Miao CY
    Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):888-96. PubMed ID: 21910745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.